Diazald-d3
CAS: 42366-72-3
Ref. 3D-SBA36672
| 1g | Descontinuado | ||
| 10mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Diazald-d3
Sinónimos:
- 4-Methyl-N-(methyl-d<sub>3</sub>)-N-nitrosobenzenesulfonamide
- Benzenesulfonamide, 4-methyl-N-(methyl-d<sub>3</sub>)-N-nitroso-
- Diazald(R)-N-Methyl-D3
- Diazald-N-Methyl-D3, 98 Atom % D
- Diazald?N-methyl-d3
- N-Methyl-D3-N-Nitroso-P-Toluenesulfonamide
- N-Methyl-N-Nitroso-P-Toluenesulfonamide (N-Methyl-D3)
- p-Toluenesulfonamide, N-methyl-d<sub>3</sub>-N-nitroso-
- 4-Methyl-N-(methyl-d3)-N-nitrosobenzenesulfonamide
- p-Toluenesulfonamide, N-methyl-d3-N-nitroso-
- Ver mais sinónimos
- Benzenesulfonamide, 4-methyl-N-(methyl-d3)-N-nitroso-
Descrição:
Diazald-d3 is a potent inhibitor of cancer cell growth and a promising medicinal compound for the treatment of various types of cancer. It targets human kinases involved in the regulation of the cell cycle, which are often overexpressed in tumor cells. Diazald-d3 has been shown to induce apoptosis and inhibit proliferation in several cancer cell lines, making it a potential anticancer agent. In addition, recent studies suggest that Diazald-d3 can be effectively delivered to cancer cells using nanoparticles, increasing its therapeutic potential. With its ability to target key proteins involved in cancer development and progression, Diazald-d3 represents a promising avenue for the development of novel cancer therapies.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
217.26 g/mol
Fórmula:
C8H10N2O3S
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
